Pharmacological approaches to the management of type 2 diabetes in fasting adults during Ramadan

Pharmacological approaches to the management of type 2 diabetes in fasting adults during Ramadan Letter (1969) Total Article Views Authors: Al Sifri S Published Date August 2012 Volume 2012:5 Pages 293 - 294 DOI: http://dx.doi.org/10.2147/DMSO.S36505 Received: 30 July 2012 Accepted: 31 July 2012 Published: 15 August 2012 Saud Al Sifri Endocrinology Department, Alhada Armed Forces Hospital, Taif, Saudi Arabia I read with great interest the recent review article by AlMaatouq regarding the pharmacological approaches to the management of type 2 diabetes in fasting adults during Ramadan.1 This article stated that "A recent prospective study of more than 1000 patients with T2DMwho fasted during Ramadan found that the risk of hypoglycemia associated with a vildagliptin-based regimen (vildagliptin 100 mg once daily) was lower than that of a sulfonylurea-based regimen (both with and without metformin)."1 This statement needs to be corrected. Ramadan is the lunar month observed each year in which Muslim adults will fast. This fast includes abstinence from eating, drinking, and smoking from sunrise to sunset. Hypoglycemia during this period represents the greatest health risk for these patients. Recently introduced modulators of the incretin system are the dipeptidylpeptidase-4 inhibitors, which include sitagliptin, vildagliptin, alogliptin, saxagliptin, and linagliptin. These agents are not associated with hypoglycemia. View original paper by AlMaatouq Post to: Cannotea Citeulike Del.icio.us Facebook LinkedIn Twitter Readers of this article also read: Epigenomics in cancer management Radio electric asymmetric brain stimulation in the treatment of behavioral and psychiatric symptoms in Alzheimer disease Randomized, double-blind, placebo-controlled, linear dose, crossover study to evaluate the efficacy and safety of a green coffee bean extract in overweight subjects Pharmacological approaches to the management of type 2 diabetes in fasting adults during Ramadan Potent antiatherosclerotic effects of alogliptin in addition to its potent antidiabetic effects Comparison with ancestral diets suggests dense acellular carbohydrates promote an inflammatory microbiota, and may be the primary dietary cause of leptin resistance and obesity Reduction in urinary albumin excretion with a moderate low-carbohydrate diet in patients with type 2 diabetes: a 12-month intervention Potential role of linagliptin as an oral once-daily treatment for patients with type 2 diabetes Nutritional therapy for the management of diabetic gastroparesis: clinical review Association of lipid profile and waist circumference as cardiovascular risk factors for overweight and obesity among school children in Qatar